A Comparative Study on Virology, Epidemiology, and Clinical Features of SARS and COVID-19

被引：3

作者：

Zhao, Yanmei ^{[1
]}

Lu, Qianying ^{[1
]}

Meng, Xiangyan ^{[1
]}

Huang, Siyu ^{[1
]}

Zhang, Jianfeng ^{[1
]}

Dong, Wenlong ^{[1
]}

Fan, Haojun ^{[1
]}

Hou, Shike ^{[1
]}

机构：

[1] Tianjin Univ, Inst Disaster & Emergency Med, Tianjin, Peoples R China

来源：

DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS | 2021年 / 17卷

基金：

中国国家自然科学基金;

关键词：

SARS; SARS-CoV-2; COVID-19; epidemic; clinical features; ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; TRANSMISSION; WUHAN; OUTBREAK; RISK;

D O I：

10.1017/dmp.2021.275

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

In December 2019, an outbreak of an unknown cause of pneumonia (later named coronavirus disease 2019 [COVID-19]) occurred in Wuhan, China. This was found to be attributed to a novel coronavirus of zoonotic origin, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously named 2019 novel coronavirus or 2019-nCoV). The SARS-CoV-2, a new type of highly pathogenic human coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV), spread rapidly worldwide and caused 246,303,023 confirmed infections, including 4,994,160 deaths, by October 31, 2021. SARS-CoV-2 and SARS-CoV vary in their specific characteristics, regarding epidemics and pathogenesis. This article focuses on the comparison of the virology, epidemiology, and clinical features of SARS-CoV and SARS-CoV-2 to reveal their common and distinct properties, to provide an up-to-date resource for the development of advanced systems and strategies to monitor and control future epidemics of highly pathogenic human coronaviruses.

引用

页数：8

共 50 条

[31] Another Decade, Another Coronavirus [J].

Perlman, Stanley .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08) :760-762

[32] Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics [J].

Petersen, Eskild ;

Koopmans, Marion ;

Go, Unyeong ;

Hamer, Davidson H. ;

Petrosillo, Nicola ;

Castelli, Francesco ;

Storgaard, Merete ;

Al Khalili, Sulien ;

Simonsen, Lone .

LANCET INFECTIOUS DISEASES, 2020, 20 (09) :E238-E244

[33] Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) [J].

Qaseem, Amir ;

Yost, Jennifer ;

Etxeandia-Ikobaltzeta, Itziar ;

Miller, Matthew C. ;

Abraham, George M. ;

Obley, Adam Jacob ;

Forciea, Mary Ann ;

Jokela, Janet A. ;

Humphrey, Linda L. .

ANNALS OF INTERNAL MEDICINE, 2020, 173 (02) :137-+

[34]

Qiu CH, 2020, OTOLARYNG HEAD NECK, V163, P714, DOI [10.1101/2020.05.13.20100198, 10.1177/0194599820934376]

[35] Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 [J].

Riou, Julien ;

Althaus, Christian L. .

EUROSURVEILLANCE, 2020, 25 (04) :7-11

[36] Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [J].

Wang, Dawei ;

Hu, Bo ;

Hu, Chang ;

Zhu, Fangfang ;

Liu, Xing ;

Zhang, Jing ;

Wang, Binbin ;

Xiang, Hui ;

Cheng, Zhenshun ;

Xiong, Yong ;

Zhao, Yan ;

Li, Yirong ;

Wang, Xinghuan ;

Peng, Zhiyong .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11) :1061-1069

[37] Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment [J].

Wang, Zhenwei ;

Chen, Xiaorong ;

Lu, Yunfei ;

Chen, Feifei ;

Zhang, Wei .

BIOSCIENCE TRENDS, 2020, 14 (01) :64-68

[38]

WHO, 2003, Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003

[39]

WHO, 2020, Keeping Health Workers Safe to Keep Patients Safe.

[40]

WHO, 2020, 56 WHO

← 1 2 3 4 5 →